Literature DB >> 10767447

Biofeedback in overactive bladder.

L D Cardozo1.   

Abstract

Biofeedback is a form of learning or re-education in which the participant is retrained within a closed feedback loop. Information about one or more of the patient's normally unconscious physiologic processes is made available to the patient as a visual, auditory, or tactile signal. Objective responses are recorded on a polygraph trace so that they can be easily observed. Subjective responses are more difficult to monitor and it is often difficult to separate these effects of biofeedback from the placebo effect. Biofeedback has been successfully employed in cases of urinary incontinence due to detrusor instability. Indeed, a recent report has shown that biofeedback-assisted behavioral treatment is more effective than either oxybutynin or placebo in the treatment of urge and mixed urinary incontinence in older, community-dwelling women. Patients embarking on biofeedback need to be well motivated and intelligent enough to understand what is expected of them. The treatment is time consuming for both the patient and the operator, but the benefits of successful treatment include a reduction in morbidity and side effects associated with other therapies. Biofeedback can be employed as an adjunct to other forms of treatment, such as drug therapy, and is particularly useful in children.

Entities:  

Mesh:

Year:  2000        PMID: 10767447     DOI: 10.1016/s0090-4295(99)00489-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Interventions for detrusor overactivity: the case for multimodal therapy.

Authors:  Roger Dmochowski
Journal:  Rev Urol       Date:  2002

2.  Vesical pacing in patients with overactive bladder: technique and results.

Authors:  Ahmed Shafik; Ismail Shafik; Olfat el-Sibai; Ali Shafik; Randa M Mostafa
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 3.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  [Initial results of Stoller peripheral neuromodulation in disorders of bladder function].

Authors:  J Pannek; M Nehiba
Journal:  Urologe A       Date:  2003-05-06       Impact factor: 0.639

Review 5.  Social, economic, and health utility considerations in the treatment of overactive bladder.

Authors:  Emilio Sacco; Daniele Tienforti; Alessandro D'Addessi; Francesco Pinto; Marco Racioppi; Angelo Totaro; Daniele D'Agostino; Francesco Marangi; Pierfrancesco Bassi
Journal:  Open Access J Urol       Date:  2010-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.